Takemasa Tsuji

4.4k total citations · 1 hit paper
83 papers, 3.1k citations indexed

About

Takemasa Tsuji is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Takemasa Tsuji has authored 83 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Immunology, 31 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Takemasa Tsuji's work include Immunotherapy and Immune Responses (40 papers), Immune Cell Function and Interaction (31 papers) and CAR-T cell therapy research (18 papers). Takemasa Tsuji is often cited by papers focused on Immunotherapy and Immune Responses (40 papers), Immune Cell Function and Interaction (31 papers) and CAR-T cell therapy research (18 papers). Takemasa Tsuji collaborates with scholars based in Japan, United States and Switzerland. Takemasa Tsuji's co-authors include Junko Matsuzaki, Sacha Gnjatic, Kunle Odunsi, Lloyd J. Old, Takashi Nishimura, Shashikant Lele, Protul Shrikant, Amy Beck, Paulette Mhawech‐Fauceglia and Feng Qian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and SHILAP Revista de lepidopterología.

In The Last Decade

Takemasa Tsuji

80 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-infiltrating NY-ESO-1–specific CD8 ⁺ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

2010 695 citations Junko Matsuzaki, Sacha Gnjatic et al. profile →

Peers

Countries citing papers authored by Takemasa Tsuji

Since Specialization

Citations

This map shows the geographic impact of Takemasa Tsuji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takemasa Tsuji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takemasa Tsuji more than expected).

Fields of papers citing papers by Takemasa Tsuji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takemasa Tsuji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takemasa Tsuji. The network helps show where Takemasa Tsuji may publish in the future.

Co-authorship network of co-authors of Takemasa Tsuji

This figure shows the co-authorship network connecting the top 25 collaborators of Takemasa Tsuji. A scholar is included among the top collaborators of Takemasa Tsuji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takemasa Tsuji. Takemasa Tsuji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs 2024 ·Cancer Immunology Research ·Bowen Dong, Nataša Obermajer, Takemasa Tsuji, Junko Matsuzaki, (unknown), Cindy Sander, Henry Withers, Mark D. Long, (unknown), Scott H. Olejniczak, Hans Minderman, John M. Kirkwood, Robert P. Edwards, Walter J. Storkus, Pedro Romero, Paweł Kaliński	3
2	Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation 2023 ·Cell Reports ·Hemn Mohammadpour, Takemasa Tsuji, Cameron R. MacDonald, (unknown), (unknown), Saeed Daneshmandi, (unknown), Jingxin Qiu, Junko Matsuzaki, Agnieszka K. Witkiewicz, Kristopher Attwood, Bruce R. Blazar, Kunle Odunsi, Elizabeth A. Repasky, Philip L. McCarthy	2
3	BiTE secretion by adoptively transferred stem-like T cells improves FRα+ ovarian cancer control 2023 ·Journal for ImmunoTherapy of Cancer ·AJ Robert McGray, (unknown), Takemasa Tsuji, Mark D. Long, (unknown), Nicole Gaulin, Spencer R. Rosario, Suzanne M. Hess, Scott I. Abrams, Danuta Kozbor, Kunle Odunsi, Emese Zsíros	6
4	Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction 2022 ·Cancer Immunology Immunotherapy ·(unknown), Takemasa Tsuji, Junko Matsuzaki, Hemn Mohammadpour, Cheryl Eppolito, Sebastiano Battaglia, Fumito Ito, Thinle Chodon, Richard C. Koya, AJ Robert McGray, Kunle Odunsi	4
5	Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy 2018 ·Cancer Immunology Research ·Takemasa Tsuji, (unknown), Junko Matsuzaki, Anthony Miliotto, (unknown), Richard C. Koya, Kunle Odunsi	13
6	HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer 2016 ·Gynecologic Oncology ·J. Brian Szender, Kevin H. Eng, Junko Matsuzaki, Anthony Miliotto, Sacha Gnjatic, Takemasa Tsuji, Kunle Odunsi	6
7	Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer 2014 ·Cancer Immunology Research ·Kunle Odunsi, Junko Matsuzaki, Smitha R. James, Paulette Mhawech‐Fauceglia, Takemasa Tsuji, Austin Miller, Wa Zhang, Stacey N. Akers, Elizabeth A. Griffiths, Anthony Miliotto, Amy Beck, Carl A. Batt, Gerd Ritter, Shashikant Lele, Sacha Gnjatic, Adam R. Karpf	153
8	Differential Antigen Expression Profile Predicts Immunoreactive Subset of Advanced Ovarian Cancers 2014 ·PLoS ONE ·Kevin H. Eng, Takemasa Tsuji	10
9	Effect of Montanide and Poly-ICLC Adjuvant on Human Self/Tumor Antigen-Specific CD4+ T Cells in Phase I Overlapping Long Peptide Vaccine Trial 2013 ·Cancer Immunology Research ·Takemasa Tsuji, Paul Sabbatini, Achim A. Jungbluth, Erika Ritter, Linda Pan, Gerd Ritter, Luis Ferran, David R. Spriggs, Andres Μ. Salazar, Sacha Gnjatic	52
10	Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4+ T Cells 2013 ·Cancer Immunology Research ·Junko Matsuzaki, Takemasa Tsuji, Immanuel F. Luescher, Lloyd J. Old, Protul Shrikant, Sacha Gnjatic, Kunle Odunsi	38
11	Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients 2013 ·Cancer Immunology Research ·Shigehisa Kitano, Takemasa Tsuji, (unknown), Daniel Hirschhorn-Cymerman, Chrisann Kyi, Zhenyu Mu, James P. Allison, Sacha Gnjatic, Jianda Yuan, Jedd D. Wolchok	96
12	Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy 2012 ·OncoImmunology ·Takemasa Tsuji, Sacha Gnjatic	6
13	Influence of CD4+CD25+ Regulatory T Cells on Low/High-Avidity CD4+ T Cells following Peptide Vaccination 2006 ·The Journal of Immunology ·Hiroyoshi Nishikawa, Feng Qian, Takemasa Tsuji, Gerd Ritter, Lloyd J. Old, Sacha Gnjatic, Kunle Odunsi	43
14	1α,25‐Dihydroxyvitamin D3 downmodulates the functional differentiation of Th1 cytokine‐conditioned bone marrow‐derived dendritic cells beneficial for cytotoxic T lymphocyte generation 2006 ·Cancer Science ·Junko Matsuzaki, Takemasa Tsuji, Yue Zhang, Daiko Wakita, Ikuo Imazeki, (unknown), Hiroaki Ikeda, Takashi Nishimura	22
15	Interpenetrated Network Formation from Poly (vinyl alcohol)/Sodium Polyalginate Aqueous Solutions and the Rheological Properties 2005 ·KOBUNSHI RONBUNSHU ·Yoshiaki Takahashi, Takemasa Tsuji, Yushu Matsushita	0
16	The critical role of type‐1 innate and acquired immunity in tumor immunotherapy 2004 ·Cancer Science ·Hiroaki Ikeda, Kenji Chamoto, Takemasa Tsuji, Yoshinori Suzuki, Daiko Wakita, Tsuguhide Takeshima, Takashi Nishimura	122
17	Th1 Cytokine-Conditioned Bone Marrow-Derived Dendritic Cells Can Bypass the Requirement for Th Functions During the Generation of CD8+ CTL 2001 ·The Journal of Immunology ·Marimo Sato, Kenji Chamoto, Takemasa Tsuji, Yoichiro Iwakura, Yuji Togashi, Toshiaki Koda, Takashi Nishimura	13
18	A Critical Role for Mouse CXC Chemokine(s) in Pulmonary Neutrophilia During Th Type 1-Dependent Airway Inflammation 2001 ·The Journal of Immunology ·Akiko Takaoka, Yoshitaka Tanaka, Takemasa Tsuji, (unknown), Akihiko Hoshino, Yumiko Asakura, (unknown), Kazuhito Watanabe, Shiro Nakaike, Yuji Togashi, Toshiaki Koda, Kouji Matsushima, Takashi Nishimura	54
19	Relationship between HLA-DR Antigen and HLA-DRB1 Alleles and Prostate Cancer in Japanese Men 1999 ·International Urology and Nephrology ·(unknown), M. Sada, Takemasa Tsuji, (unknown), Yoji Katsuoka	5
20	HLA‐DR Antigen and HLA‐DRB1 Genotyping with Nonobstructive Azoospermia in Japan 1999 ·Journal of Andrology ·Akira Tsujimura, Shiro Takahara, (unknown), (unknown), Minoru Koga, Masaharu Sada, Takemasa Tsuji, Kiyomi Matsumiya, Äkïhïko Okuyama	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact